liver
The findings of a new research reveal the microbiota alterations during NAFLD and suggest that gut microbes can be used as an early clinical sign of the condition.
The current knowledge of the gut-liver axis in NAFLD may lead to the development of microbiota-based personalized approaches for managing the condition.
Researchers have found that the development of liver cancer can be associated with alterations of the gut microbiota.
A new study, published in Cell Metabolism, identified a microbial signature that is able to diagnose cirrhosis in people.
A study published in Cell Metabolism shows that the gut microbiota can act at a distance to protect against liver damage.
MetaboGen is active in the field of live biotherapeutic products and on the study of liver diseases. We discussed their approach with Sara Malcus, CEO of the company.
